Health Me Medical CenterHealth Me Medical
Health Me Medical Center

Health Me Medical

Emergency
911
Add doctors or trusted contacts with phone numbers for quick dial

Finish setting up your health profile

Takes about 2 minutes — tailors your AI care team to you.

Start setup
Health Me Medical Center — Your Health • Our Mission • A Brighter Future

Contact Us

Have a question, feedback, or a partnership idea? Fill out the form below and our team will get back to you.

0 / 5000

Email

Replies are sent to the email you provide in the form.

Emergency?

For medical emergencies, call 911 immediately — do not use this form.

Health Me Medical Center — Quality Care for a Healthier Tomorrow. No co-pays, free healthcare, free dental care, free eye care, and 24/7 access. AI doctor consultation, virtual consultations, AI nurse, mental health specialist, and much more.

Health Me Medical Center is an AI-powered wellness companion, not a medical provider. It provides health information and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for medical concerns. In an emergency, call 911.

View Terms of Service & Privacy Policy

News
1. Stryker Corporation announced the appointment of a new CEO as Kevin Lobo transitions to the role of chairman on October 6, 2026. ◆ 2. GE HealthCare expanded its strategic presence in the United States radiopharmaceutical market as of October 6, 2026. ◆ 3. Public health officials and emergency responders participated in coordinated mental health briefings held on October 6, 2026. ◆ 4. The American Association for Cancer Research released a comprehensive summary of third-quarter 2026 oncology drug approvals on October 5, 2026. ◆ 5. Recent clinical data from Q3 2026 highlights the approval of 22 new therapies for nephrology, including enlicitide and daraxonrasib. ◆ 6. The FDA approved Emcitate (tiratricol) for the treatment of patients with MCT8 deficiency on September 28, 2026. ◆ 7. The FDA approved Degevma (denosumab-adet) as a biosimilar to Xgeva on September 28, 2026. ◆ 8. Medical researchers published an updated analysis of hantavirus outbreak patterns from the Four Corners region to the MV Hondius on September 30, 2026. ◆ 9. The FDA approved Pixclara (floretyrosine F 18) as a new FET-PET imaging agent for glioma on September 14, 2026. ◆ 10. The FDA granted approval for the first treatment for children aged 4-11 years with APDS, a rare genetic immune disorder, on September 11, 2026.1. Stryker Corporation announced the appointment of a new CEO as Kevin Lobo transitions to the role of chairman on October 6, 2026. ◆ 2. GE HealthCare expanded its strategic presence in the United States radiopharmaceutical market as of October 6, 2026. ◆ 3. Public health officials and emergency responders participated in coordinated mental health briefings held on October 6, 2026. ◆ 4. The American Association for Cancer Research released a comprehensive summary of third-quarter 2026 oncology drug approvals on October 5, 2026. ◆ 5. Recent clinical data from Q3 2026 highlights the approval of 22 new therapies for nephrology, including enlicitide and daraxonrasib. ◆ 6. The FDA approved Emcitate (tiratricol) for the treatment of patients with MCT8 deficiency on September 28, 2026. ◆ 7. The FDA approved Degevma (denosumab-adet) as a biosimilar to Xgeva on September 28, 2026. ◆ 8. Medical researchers published an updated analysis of hantavirus outbreak patterns from the Four Corners region to the MV Hondius on September 30, 2026. ◆ 9. The FDA approved Pixclara (floretyrosine F 18) as a new FET-PET imaging agent for glioma on September 14, 2026. ◆ 10. The FDA granted approval for the first treatment for children aged 4-11 years with APDS, a rare genetic immune disorder, on September 11, 2026.